ScholarLens Back to search
1988•RADIOISOTOPESOpen access

The clinical evaluation of the serum SCC antigen levels with "SCC RIABEAD" by immunoradiometric assay.

Yasuko YOSHIDA, Hitoshi TAKASHIMA, Yukiko KAWASAKI, Sadatoshi YASUDA, Toyosato TAMAI, Nobuyuki HOSOKAWA, Tutomu MIYAMOTO, Shinsuke MATUNO, Kazuhiro SAKAMOTO, Setuo Nakase, Masatada TANABE

Open full text 0 citations

Abstract

The clinical significance of serum SCC antigen level was evaluated by the monoclonal antibody method (SCC.RIABEAD Dinabot Co. Ltd). Patients with squamous cell carcinoma showed a high positive SCC antigen level and positive rate elevated with the advance of the clinical stage. The serum SCC antigen level was decreased by treatment, and it increased again before obvious clinical recurrence was recognized. The results suggest that measurement of serum SCC antigen level is useful as a follow up of cancer treatment.

Open-access reader

About this research paper

What this paper is about

The clinical significance of serum SCC antigen level was evaluated by the monoclonal antibody method (SCC.RIABEAD Dinabot Co. Ltd). Patients with squamous cell carcinoma showed a high positive SCC antigen level and positive rate elevated with the advance of the clinical stage. The serum SCC antigen level was decreased by treatment, and it increased again before obvious clinical recurrence was recognized. The results suggest that measurement of serum SCC antigen level is useful as a follow up of cancer treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The clinical significance of serum SCC antigen level was evaluated by the monoclonal antibody method (SCC.RIABEAD Dinabot Co. Ltd). Patients with squamous cell carcinoma showed a high positive SCC antigen level and positive rate elevated with the advance of the clinical stage. The serum SCC antigen level was decreased by treatment, and it increased again before obvious clinical recurrence was recognized. The results suggest that measurement of serum SCC antigen level is useful as a follow up of cancer treatment.

Key concepts: Immunoradiometric assay, Antigen, Radioimmunoassay, Medicine, Clinical significance, Monoclonal antibody, Internal medicine, Antibody

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The clinical evaluation of the serum SCC antigen levels with "SCC RIABEAD" by immunoradiometric assay. — Research Paper | ScholarLens